Neurostimulation
therapy is used for treatment and diagnosis of nervous
disorder. It reduces chronic pain associated with conditions such as
Parkinson’s disease, epilepsy, nociceptive pain, neuropathic pain,
and depression. It helps to improve quality of life of patients
suffering from paralysis, obesity, and severe loss of sensory organs.
Neurostimulation devices is a key element used in neural prosthetics
for artificial vision, artificial limbs, and hearing aids. They
include implantable and non-implantable devices, which deliver
chemical, electrical or other agents that reversibly modify nerve
cell activity and brain cells. They are surgically inserted into the
patient organs and are operated with the help of thin wires and
leads.
Download
PDF Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/430
Intracranial
stimulation, peripheral nerve stimulation (PNS), Spinal cord
stimulation (SCS), deep brain stimulation, and motor cortex
stimulation are among the most widely used neurostimulation devices.
As per the data published by European Brain Council, worldwide around
6.3 million people were suffering from Parkinson’s disease in 2015
and the number is expected to increase steadily in the near future.
Spinal cord stimulation is widely used in failed back surgery, pain
due to peripheral neuropathy, and pain due to low supply of blood to
the limb, chest pain, urinary incontinence, and occipital neuralgia.
The deep brain stimulation is generally use to treat Parkinson’s
plus syndromes.
Increasing prevalence of Parkinson’s disease is expected to fuel
growth of neurostimulation devices market
According
to National Institutes of Health (NIH), around 50,000 people were
suffering from Parkinson disease (PD) in the U.S. North America
accounted for largest share in neurostimulation devices market and is
expected to retain its dominance through the forecast period, owing
to increasing patient awareness regarding treatment of disease and
increasing investments on healthcare in this region. Asia Pacific is
projected to be the fastest growing market, owing to high prevalence
of PD in economies such as India and China.
Top Key Players
Some
of the major players operating in neurostimulation devices market
include Virtual Medical Centre Inc Neurosigma, Boston Scientific
Corporation, St. Jude Medical Inc., NDI Medical, electroCore LLC,
Electro Medics, Endostim Inc., and NeuroPace, Inc.
Neurostimulation Devices Market Taxonomy
Global Neurostimulation Devices Market by Device Type
•
Deep Brain Stimulators
•
Gastric Electric Stimulators
•
Sacral Nerve Stimulators
•
Vagus Nerve Stimulators
•
Spinal Cord Stimulators
•
Others
Global Neurostimulation Devices Market by Application
•
Parkinson's Disease
•
Depression
•
Essential Tremor
•
Urinary and Fecal Incontinence
•
Gastroparesis
•
Others
Global Neurostimulation Devices Market by End User
•
Hospitals
•
Rehabilitation Centers
•
Medical Clinic
Global Neurostimulation Devices Market by Geography
•
North America
•
Latin America
•
Europe
•
Asia Pacific
•
Middle East
•
Africa
Grab
Your Report at an Impressive Discount @
https://www.coherentmarketinsights.com/insight/request-discount/430
About Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment